SYNOVIAL SARCOMA

Clinical trials for SYNOVIAL SARCOMA explained in plain language.

Never miss a new study

Get alerted when new SYNOVIAL SARCOMA trials appear

Sign up with your email to follow new studies for SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 15 Not yet recruiting 1 Not yet finished but already full! 9 Completed 5 Terminated 1

Experimental cancer drug LY3405105 fails to advance in early trial

Disease control Terminated

This early-phase study tested the safety of an oral drug called LY3405105 in 54 people with advanced solid tumors. The trial was divided into two parts to find the right dose and to see if the drug could shrink tumors. However, the study was terminated early, meaning the drug did…

Matched conditions: SYNOVIAL SARCOMA

Phase: PHASE1 • Sponsor: Eli Lilly and Company • Aim: Disease control

Last updated Jun 27, 2026 07:56 UTC

SYNOVIAL SARCOMA

Get alerted when new SYNOVIAL SARCOMA trials appear

Experimental cancer drug LY3405105 fails to advance in early trial